A. E. Eskazan Et Al. , "Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia," 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , vol.128, California, United States Of America, 2016
Eskazan, A. E. Et Al. 2016. Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia. 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (California, United States Of America).
Eskazan, A. E., Oztas, M., Bektas, F., Sadri, S., Keskin, D., Yurttas, N. O., ... Berk, S.(2016). Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia . 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America
Eskazan, Ahmet Et Al. "Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia," 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 2016
Eskazan, Ahmet E. Et Al. "Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia." 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , California, United States Of America, 2016
Eskazan, A. E. Et Al. (2016) . "Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia." 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , California, United States Of America.
@conferencepaper{conferencepaper, author={Ahmet Emre EŞKAZAN Et Al. }, title={Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia}, congress name={58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={California}, country={United States Of America}, year={2016}}